Celldex Therapeutics shares owned by Rise Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Rise Advisors
from 13F filings
Historical chart of Rise Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Rise Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Rise Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $3.5k | 83 | 41.98 |
| 2023-12-31 | $3.3k | 83 | 39.66 |
| 2023-09-30 | $2.3k | 83 | 27.52 |
| 2023-06-30 | $2.8k | 83 | 33.93 |
| 2023-03-31 | $3.0k | 83 | 35.98 |
| 2022-12-31 | $3.7k | 83 | 44.57 |
| 2022-09-30 | $2.0k | 83 | 24.10 |
| 2022-06-30 | $2.0k | 83 | 24.10 |
| 2022-03-31 | $3.0k | 83 | 36.14 |
| 2021-12-31 | $3.2k | 83 | 38.64 |